临床试验雷达

测试版

试验雷达 AI 患者护理人员医疗专业人士生物技术专业人士生物技术投资者研究人员其他
	让我们一起探讨并了解由 AstraZeneca 担任主要申办者或合作伙伴的临床试验。正在显示糖尿病的临床试验。我可以帮助您了解健康状况、治疗方法，并找到附近的临床试验。

我们的搜索工具目前仅支持英文。若要使用其他语言进行搜索和讨论，请使用上方的试验雷达 AI，或使用下方的疾病和研究地点筛选器。

按关键词搜索...

按研究中心或机构名称搜索...

研究标题	试验状态
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505	已终止
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848	已完成
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383	已完成结果已发布
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus NCT00108004	已完成
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin NCT00701935	已终止结果已发布
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes NCT00064714	已完成
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus NCT01095991	已完成
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus NCT01082120	已完成
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396	已完成结果已发布
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus (IRAK4) NCT07433062	招募中
Impact of Diabetes on Left Ventricular Remodeling (P3) NCT01052272	已完成结果已发布
AZD5004每日一次口服给药与安慰剂在26周内对2型糖尿病成年患者的疗效、安全性和耐受性研究 (SOLSTICE) NCT06579105	已完成
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979	已完成结果已发布
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612	已完成结果已发布
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old NCT03199053	已完成结果已发布
Evaluation of the Effect of Pramlintide on Satiety and Food Intake NCT00042601	已完成
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients NCT04445714	已完成结果已发布
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313	已完成结果已发布
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385	已完成结果已发布
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082	已完成结果已发布
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes NCT00229658	已完成结果已发布
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244	已完成结果已发布
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015	已完成结果已发布
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123	已完成结果已发布
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (FORTUNA) NCT01140542	已完成
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705	已完成结果已发布
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus NCT00313183	已完成
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC) NCT02426541	已完成结果已发布
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus NCT01206647	状态未知
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT02367066	已完成结果已发布
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374	已完成结果已发布
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients NCT00658463	已完成
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067	已完成
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT01165268	已完成
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes NCT03377335	状态未知
Bioequivalence Study NCT01874080	已完成
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes NCT00229710	已终止
Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes NCT04556760	已完成结果已发布
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795	已完成结果已发布
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients NCT01055652	已完成
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus NCT00226330	已终止
Evaluation of the Bioavailability of Pramlintide NCT00042471	已完成
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus NCT00135330	已完成结果已发布
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus NCT01876849	已完成
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (GENERATION) NCT01006603	已完成结果已发布
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214	已完成结果已发布
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978	已完成结果已发布
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus NCT00107107	已完成
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (PROMPT) NCT01006590	已完成结果已发布
Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (FLORA) NCT02719132	已撤回

临床试验雷达

试验分期 (阶段)

类型

试验类型

年龄组

生物性别

安慰剂

试验分期 (阶段)

类型

试验类型

年龄组

生物性别